W STRATEGIES, LLC

Lobbying for ABBVIE INC. · Biopharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Education and legislation related to reform of the 340(b) program. Education around data privacy.

Medicare/Medicaid

Medicare Implementation of the Inflation Reduction Act. Public Law 119-21: One Big Beautiful Bill Act. Issues around drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.